Stock listing

HPHA Stock Price, News, Filings & Events — Heidelberg Pharma Ag

Selected listing: HPHA · XETR · EUR · DE

This page tracks Heidelberg Pharma Ag's HPHA:XETR listing on XETR in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following HPHA:XETR. HPHA:XETR is the stock-level entry point for investors researching Heidelberg Pharma Ag, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Heidelberg Pharma AG is a public company listed on the German market under the ticker HPHA. The company has a market capitalization of approximately €136.5 million. Heidelberg Pharma focuses on developing innovative therapies, particularly in the field of cancer treatment.

HPHA:XETREURDEUpdated September 11, 2026
Heidelberg Pharma Ag logo
Ticker
HPHA:XETR
Asset type
Stock
Market cap
$133.1M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
XETR
Currency
EUR

Heidelberg Pharma Ag HPHA:XETR stock context

This page tracks Heidelberg Pharma Ag's HPHA:XETR listing on XETR in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following HPHA:XETR. HPHA:XETR is the stock-level entry point for investors researching Heidelberg Pharma Ag, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Heidelberg Pharma AG is a public company listed on the German market under the ticker HPHA. The company has a market capitalization of approximately €136.5 million. Heidelberg Pharma focuses on developing innovative therapies, particularly in the field of cancer treatment.

Latest news from Heidelberg Pharma Ag

All Heidelberg Pharma Ag news →

Research Heidelberg Pharma Ag

Alternate listings